Testing effectiveness (Phase 2)Study completedNCT00803010
What this trial is testing
Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation
Who this might be right for
Acute Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 74